CFR Pharmaceuticals Announces Exemption From The Takeover Regulation Panel ("TRP") And Confirmation That The Termination Agreement Concluded On 7 February 2014 ("Termination Agreement") Is Now Effective

Published: Feb 13, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SANTIAGO, Chile, Feb. 13, 2014 (GLOBE NEWSWIRE) -- CFR Pharmaceuticals S.A. (SSE:CFR), the Chilean multinational emerging markets pharmaceutical company, leader in specialties and prescription medicines, refers shareholders to the announcement released on the Stock Exchange News Service of the JSE Limited by Adcock Ingram and CFR ("the Parties") on Friday, February 7, 2014, advising that the Parties had entered into a Termination Agreement providing for the consensual termination of the Transaction Implementation Agreement concluded between the Parties on 11 September 2013, as amended ("TIA") and the termination of the scheme of arrangement proposed between Adcock Ingram and the holders of Adcock Ingram ordinary shares (other than the holders of A and B ordinary shares and treasury shares) in relation to the CFR offer ("Scheme").

Help employers find you! Check out all the jobs and post your resume.

Back to news